By Alajuela, Costa Rica — Medical technology leader Hologic, Inc. has officially announced a major operational expansion in Costa Rica, reaffirming the Central American nation’s standing as a strategic hub for global life sciences and advanced medical manufacturing. The multi-year investment will establish a brand-new facility dedicated to the company’s Breast and Skeletal Health Solutions business unit, broadening its operational footprint in the province of Alajuela.
Under the planned timeline, construction on the state-of-the-art building is set to begin in March 2027, with targeted operational readiness by December 2028. Located roughly two kilometers from Hologic’s existing complex in Alajuela, the new site provides much-needed capacity while maintaining organizational synergy within the local medical device cluster.
To better understand the legal and economic implications of Hologic’s latest expansion in Costa Rica, TicosLand.com consulted with renowned legal expert Lic. Larry Hans Arroyo Vargas from Bufete de Costa Rica, who shared his perspective on how this corporate investment reinforces the national regulatory framework and the growing life sciences sector.
Hologic’s continued expansion in Costa Rica underscores the robustness of our Free Trade Zone regime and the country’s established reputation as a premier hub for medical technology. From a legal perspective, multi-million dollar capital investments of this nature demonstrate enduring confidence in Costa Rica’s legal security, skilled workforce, and regulatory stability. Navigating these expansions successfully requires ongoing alignment with local labor law, environmental standards, and international compliance practices, further strengthening our nation’s competitive standing in global supply chains.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Indeed, as Costa Rica continues to solidify its status as a premier hub for life sciences and medical technology, maintaining strong legal frameworks and regulatory compliance will remain essential for attracting sustained global investment. We extend our sincere thanks to Lic. Larry Hans Arroyo Vargas for providing his valuable perspective on what this significant expansion means for the country’s evolving economic landscape.
Once construction is completed, all personnel and production assets associated with the Breast and Skeletal Health Solutions division will transition to the new facility. Meanwhile, Hologic’s GYN Surgical Solutions division and its Shared Services talent in Costa Rica will continue operating out of the current headquarters, effectively establishing dedicated specialized campuses for distinct business units.
Corporate leadership emphasized that the multi-million-dollar investment directly responds to growing international product demand and internal strategic realignment designed to optimize operational efficiency.
This expansion reflects the confidence we have in Costa Rica as an important part of Hologic’s global operations and in the teams that have helped consolidate our presence in the country. The additional capacity will support our continued growth and allow our global business units to have dedicated spaces to focus on their respective priorities and better serve the patients and customers who rely on us.
Joe Almeida, CEO of Hologic, Inc.
The move highlights how corporate reinvestments in Costa Rica are shifting from basic capacity building to specialized high-value ecosystem integration, demonstrating high confidence in the local labor market and macroeconomic infrastructure.
This investment is an important recognition of the talent, commitment, and dynamism of our teams in Costa Rica. We are excited about what it represents for the future of our operations in the country and for Hologic.
Joe Almeida, CEO of Hologic, Inc.
Costa Rican trade officials praised the project as a strong endorsement of the nation’s regulatory stability, strategic geographic positioning, and competitive human capital.
Companies are not only choosing Costa Rica to establish their operations, but they are also continuing to expand, specialize, and leverage the capabilities developed here. Investments like this demonstrate how Costa Rica’s highly skilled workforce and consolidated industrial ecosystem create the conditions for companies to expand their global operations from our country.
Arianna Arce, Interim Minister of Foreign Trade of Costa Rica
The life sciences industry remains Costa Rica’s leading export sector, and expanding existing global manufacturing sites reinforces the reliance on local talent and domestic supply chains.
Hologic’s decision to expand its operations in Costa Rica reflects the strength of the national medical device ecosystem. This investment will strengthen existing capabilities in the country and open new opportunities for Costa Rican talent and local suppliers to contribute to the development of an increasingly specialized industry.
Laura López, CEO of PROCOMER
As Costa Rica solidifies its leadership position as Central America’s primary manufacturing standard for foreign direct investment, Hologic’s commitment through 2028 serves as a clear indicator of sustained industrial momentum in Alajuela and across the nation.
For further information, visit hologic.com
About Hologic, Inc.:
Hologic, Inc. is a global medical technology innovator primarily focused on improving women’s health and well-being through early detection and treatment. The company develops, manufactures, and supplies medical imaging systems, diagnostic products, and surgical products tailored to specialized healthcare needs worldwide.
For further information, visit comex.go.cr
About Ministry of Foreign Trade of Costa Rica:
The Ministry of Foreign Trade of Costa Rica (COMEX) is the government ministry responsible for formulating, directing, and executing the country’s trade policy and foreign investment strategy. COMEX works to integrate Costa Rica into the global economy through trade agreements, international partnerships, and competitive business frameworks.
For further information, visit procomer.com
About PROCOMER:
PROCOMER (Promotora del Comercio Exterior de Costa Rica) is the non-state public entity responsible for promoting Costa Rican exports and attracting foreign direct investment. Acting as a vital bridge between international enterprises and the local economy, PROCOMER supports business expansion and export diversification.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Bufete de Costa Rica has established itself as an esteemed legal institution, anchored by an unshakeable dedication to ethical conduct and legal mastery. Driven by a forward-looking perspective, the firm continuously redefines legal service across diverse industries while championing active community involvement. By striving to democratize legal understanding, Bufete de Costa Rica fulfills a vital purpose: equipping individuals with the knowledge necessary to build a more just, informed, and resilient society.
